Occupational risk of nano-biomaterials: Assessment of nano-enabled magnetite contrast agent using the BIORIMA Decision Support System.

Contrast Media / adverse effects Ferrosoferric Oxide Humans Occupational Exposure Risk Assessment / methods Risk Management Workplace
Decision Support System Magnetite nanoparticles Nano-biomaterials Occupational risk assessment

Journal

NanoImpact
ISSN: 2452-0748
Titre abrégé: NanoImpact
Pays: Netherlands
ID NLM: 101676795

Informations de publication

Date de publication:
01 2022
Historique:
received: 03 09 2021
revised: 24 11 2021
accepted: 02 12 2021
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 20 5 2022
Statut: ppublish

Résumé

The assessment of the safety of nano-biomedical products for patients is an essential prerequisite for their market authorization. However, it is also required to ensure the safety of the workers who may be unintentionally exposed to the nano-biomaterials (NBMs) in these medical applications during their synthesis, formulation into products and end-of-life processing and also of the medical professionals (e.g., nurses, doctors, dentists) using the products for treating patients. There is only a handful of workplace risk assessments focussing on NBMs used in medical applications. Our goal is to contribute to increasing the knowledge in this area by assessing the occupational risks of magnetite (Fe

Identifiants

DOI: 10.1016/j.impact.2021.100373 PMID: 35559879
pubmed: 35559879
pii: S2452-0748(21)00082-3
doi: 10.1016/j.impact.2021.100373
pii:
doi:

Substances chimiques

Contrast Media 0
Ferrosoferric Oxide XM0M87F357

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100373

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

V Cazzagon (V)

Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari of Venice, via Torino 155, 30170 Venice Mestre, Italy.

E Giubilato (E)

Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari of Venice, via Torino 155, 30170 Venice Mestre, Italy; GreenDecision S.r.l., 30170 Venice Mestre, Italy. Electronic address: giubilato@unive.it.

L Pizzol (L)

GreenDecision S.r.l., 30170 Venice Mestre, Italy.

C Ravagli (C)

COLOROBBIA CONSULTING S.r.l., Ce.Ri.Col. Centro Ricerche Colorobbia, Via Pietramarina, 123, 50053 Sovigliana, Vinci (FI), Italy.

S Doumett (S)

COLOROBBIA CONSULTING S.r.l., Ce.Ri.Col. Centro Ricerche Colorobbia, Via Pietramarina, 123, 50053 Sovigliana, Vinci (FI), Italy.

G Baldi (G)

COLOROBBIA CONSULTING S.r.l., Ce.Ri.Col. Centro Ricerche Colorobbia, Via Pietramarina, 123, 50053 Sovigliana, Vinci (FI), Italy.

M Blosi (M)

Institute of Science and Technology for Ceramics (CNR-ISTEC), National Research Council of Italy, Via Granarolo 64, 48018 Faenza, RA, Italy.

A Brunelli (A)

Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari of Venice, via Torino 155, 30170 Venice Mestre, Italy.

C Fito (C)

ITENE, C/ Albert Einstein, 1, 46980 Paterna, Valencia, Spain.

F Huertas (F)

ITENE, C/ Albert Einstein, 1, 46980 Paterna, Valencia, Spain.

A Marcomini (A)

Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari of Venice, via Torino 155, 30170 Venice Mestre, Italy.

E Semenzin (E)

Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari of Venice, via Torino 155, 30170 Venice Mestre, Italy.

A Zabeo (A)

GreenDecision S.r.l., 30170 Venice Mestre, Italy.

I Zanoni (I)

Institute of Science and Technology for Ceramics (CNR-ISTEC), National Research Council of Italy, Via Granarolo 64, 48018 Faenza, RA, Italy.

D Hristozov (D)

Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari of Venice, via Torino 155, 30170 Venice Mestre, Italy. Electronic address: danail.hristozov@unive.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits de contraste › Occupational risk of nano-biomaterials:...
questionsmedicales.fr › Produits chimiques inorganiques › Minéraux › Oxyde ferrosoferrique › Occupational risk of nano-biomaterials:...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Occupational risk of nano-biomaterials:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Exposition environnementale › Exposition professionnelle › Occupational risk of nano-biomaterials:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Occupational risk of nano-biomaterials:...
questionsmedicales.fr › Administration des services de santé › Organisation et administration › Gestion du risque › Occupational risk of nano-biomaterials:...
questionsmedicales.fr › Administration des services de santé › Organisation et administration › Gestion du personnel › Lieu de travail › Occupational risk of nano-biomaterials:...